Bonness Enterprises Inc. Sells 15,755 Shares of Koninklijke Philips (NYSE:PHG)

Bonness Enterprises Inc. lowered its position in shares of Koninklijke Philips (NYSE:PHG) by 15.2% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 88,062 shares of the technology company’s stock after selling 15,755 shares during the quarter. Koninklijke Philips accounts for approximately 0.8% of Bonness Enterprises Inc.’s investment portfolio, making the stock its 23rd biggest holding. Bonness Enterprises Inc.’s holdings in Koninklijke Philips were worth $2,230,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Fairscale Capital LLC bought a new stake in Koninklijke Philips during the second quarter worth $54,000. Wilmington Savings Fund Society FSB purchased a new stake in shares of Koninklijke Philips during the 3rd quarter valued at $54,000. Eastern Bank bought a new stake in shares of Koninklijke Philips during the 3rd quarter worth $88,000. RPg Family Wealth Advisory LLC purchased a new position in shares of Koninklijke Philips in the 3rd quarter worth about $107,000. Finally, Clifford Capital Partners LLC bought a new position in Koninklijke Philips during the second quarter valued at about $201,000. Institutional investors own 13.67% of the company’s stock.

Koninklijke Philips Trading Up 0.3 %

NYSE PHG opened at $25.82 on Tuesday. The company’s 50 day moving average is $25.85 and its 200-day moving average is $28.09. Koninklijke Philips has a 12-month low of $19.55 and a 12-month high of $32.91. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74.

Analysts Set New Price Targets

A number of research analysts have weighed in on the stock. StockNews.com cut shares of Koninklijke Philips from a “buy” rating to a “hold” rating in a research note on Thursday, November 14th. Jefferies Financial Group upgraded Koninklijke Philips from an “underperform” rating to a “hold” rating in a research note on Tuesday, October 29th. Five analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.